POU6F2 has been reported to be expressed also in the developing midbrain (8), pituitary (10), and kidneys (11), and mutations of POU6F2 have been identified in prolactinomas (12) and in a hereditary predisposition to Wilms tumor (nephroblastomas; 13). This evidence concerns the gene POU6F2 and Wilms tumor.